Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosa
- PMID: 4014087
- DOI: 10.1001/archpedi.1985.02140090031019
Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosa
Abstract
Allergy and chronic Pseudomonas aeruginosa (PA) infection are two factors that possibly affect the clinical severity of cystic fibrosis pulmonary disease, although the role of allergy is controversial. We have examined the effects of these factors on actuarial survival rates in 117 children with cystic fibrosis who were skin tested in 1974 and classified as allergic (A+) or nonallergic (A-) by their reactions to 12 prick tests with common environmental allergens. Patients were also classified according to whether or not they had chronic pulmonary infection with PA in 1974 (PA-positive or PA-negative). Survival rates in A+ patients were not significantly different from those in the A- group (percent survival to age 16 years, 67% vs 80%), whereas the PA+ group had significantly worse survival rates than the PA- group (percent survival to age 16 years, 53% vs 84%). There was no significant interaction between allergic skin reactions and either age at onset of chronic PA infection or subsequent duration of survival.
Similar articles
-
Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection.J Clin Epidemiol. 1995 Aug;48(8):1041-9. doi: 10.1016/0895-4356(94)00230-n. J Clin Epidemiol. 1995. PMID: 7775991
-
Pseudomonas infection, allergy, and cystic fibrosis.Arch Dis Child. 1982 Aug;57(8):582-6. doi: 10.1136/adc.57.8.582. Arch Dis Child. 1982. PMID: 6981383 Free PMC article.
-
DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.Clin Respir J. 2016 Nov;10(6):777-783. doi: 10.1111/crj.12288. Epub 2015 Apr 15. Clin Respir J. 2016. PMID: 25763772
-
[Pseudomonas aeruginosa and cystic fibrosis: first colonization to chronic infection].Arch Pediatr. 2006 Oct;13 Suppl 1:S22-9. Arch Pediatr. 2006. PMID: 17370393 Review. French.
-
Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.Curr Med Res Opin. 2012 Jun;28(6):1059-67. doi: 10.1185/03007995.2012.674500. Epub 2012 May 10. Curr Med Res Opin. 2012. PMID: 22401602 Review.
Cited by
-
Population transcript accumulation of Pseudomonas aeruginosa exotoxin A and elastase in sputa from patients with cystic fibrosis.Infect Immun. 1992 Nov;60(11):4687-94. doi: 10.1128/iai.60.11.4687-4694.1992. Infect Immun. 1992. PMID: 1383155 Free PMC article.
-
Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1994 May;38(5):1090-5. doi: 10.1128/AAC.38.5.1090. Antimicrob Agents Chemother. 1994. PMID: 8067743 Free PMC article.
-
Segregation is good for patients with cystic fibrosis.J R Soc Med. 2008 Jul;101 Suppl 1(Suppl 1):S31-5. doi: 10.1258/jrsm.2008.s18007. J R Soc Med. 2008. PMID: 18607016 Free PMC article. No abstract available.
-
Clinical significance of microbial infection and adaptation in cystic fibrosis.Clin Microbiol Rev. 2011 Jan;24(1):29-70. doi: 10.1128/CMR.00036-10. Clin Microbiol Rev. 2011. PMID: 21233507 Free PMC article. Review.
-
Infection-induced airway fibrosis in two rat strains with differential susceptibility.Infect Immun. 1992 Jul;60(7):2936-42. doi: 10.1128/iai.60.7.2936-2942.1992. Infect Immun. 1992. PMID: 1612760 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical